Mitochondrial dysfunction in psychiatric morbidity: current evidence and therapeutic prospects
Lilach Toker,1 Galila Agam2,3 1Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada; 2Department of Clinical Biochemistry and Pharmacology, Ben-Gurion University of the Negev, Beer-Sheva, Israel; 3Mental Health Center, Beer-Sheva, Israel Abstract: Cumulating evidence for...
Guardado en:
Autores principales: | Toker L, Agam G |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9d8de12cec6f4f17b7f8a31ca45b8931 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tackling nonadherence in psychiatric disorders: current opinion
por: Farooq S, et al.
Publicado: (2014) -
Current perspectives on deep brain stimulation for severe neurological and psychiatric disorders
por: Kocabicak E, et al.
Publicado: (2015) -
Mitochondrial dysfunction, oxidative stress, and major depressive disorder
por: Tobe EH
Publicado: (2013) -
Current approaches to treatments for schizophrenia spectrum disorders, part II: psychosocial interventions and patient-focused perspectives in psychiatric care
por: Chien WT, et al.
Publicado: (2013) -
Psychiatric diagnoses in patients with burning mouth syndrome and atypical odontalgia referred from psychiatric to dental facilities
por: Miho Takenoshita, et al.
Publicado: (2010)